Prevalence and treatment of arterial hypertension among patients with biopsy proven nonalcoholic fatty liver disease

被引：0
|
作者：
Steffen, H. -M. [1 ]
Schulte, S. [1 ]
Lengerli, K. [1 ]
Rodmanis, C. [1 ]
Demir, M. [1 ]
Goeser, T. [1 ]
机构：
[1] U Tox Univ Cologne, Abdominal Ctr, Dept Gastroenterol & Hepatol, Cologne, Germany
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [31] EARLY CARDIAC DYSFUNCTION IN BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Johnson, Peter C.
    Cochet, Anthony A.
    Gore, Rosco S.
    Harrison, Stephen A.
    Magulick, John P.
    Aden, James K.
    Paredes, Angelo H.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1174 - S1174
  • [32] Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease
    Wegermann, Kara
    Fudim, Marat
    Henao, Ricardo
    Howe, Catherine F.
    McGarrah, Robert
    Guy, Cynthia
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    Moylan, Cynthia A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [33] External Validation of the Nonalcoholic Steatohepatitis Scoring System in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease in China Reply
    Koo, Bo Kyung
    Kim, Won
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (02) : 413 - 414
  • [34] Prevalence of nonalcoholic fatty liver disease in hypertensive patients
    Stagni, B
    Donati, G
    Serra, C
    Piscaglia, F
    Valgimigli, M
    Tumscitz, C
    Chiodarelli, C
    Crespi, C
    Pini, P
    Rasciti, L
    Tisselli, N
    Bolondi, L
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S26 - S26
  • [35] Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
    Golubeva, Julia A.
    Sheptulina, Anna F.
    Elkina, Anastasia Yu.
    Liusina, Ekaterina O.
    Kiselev, Anton R.
    Drapkina, Oxana M.
    [J]. BIOMEDICINES, 2023, 11 (09)
  • [36] Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients
    Wang, Qingling
    Zhu, Mingyu
    Li, Hu
    Chen, Peizhan
    Wang, Mingjie
    Gu, Leilei
    Zhang, Xinxin
    Chen, Li
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1543 - 1552
  • [37] VITAMIN D DEFICIENCY, A NONINVASIVE MARKER OF STEATOHEPATITIS IN PATIENTS WITH OBESITY AND BIOPSY PROVEN NONALCOHOLIC FATTY LIVER DISEASE
    Livadariu, R.
    Timofte, D.
    Trifan, A.
    Danila, R.
    Ionescu, L.
    Singeap, A. M.
    Ciobanu, D.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (01) : 76 - 84
  • [38] Reply to: Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease
    Lee, Hyun Woo
    Kim, Won
    Kim, Deog Kyeom
    [J]. LIVER INTERNATIONAL, 2021, 41 (01) : 243 - 244
  • [39] Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Spengler, Erin K.
    Loomba, Rohit
    [J]. MAYO CLINIC PROCEEDINGS, 2015, 90 (09) : 1233 - 1246
  • [40] Cardiac dysfunction in a cohort of biopsy proven nonalcoholic steatohepatitis in comparison to nonalcoholic fatty liver
    Varghese, Jijo
    Devadas, Krishnadas
    Vinayakumar, Neeraj
    Nahaz, Nibin
    Hareendran, Atul
    Oommen, Tharun Tom
    George, Bony
    [J]. EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
12345